Pharmaceutical Resources launching Nutraceutical Resources melatonin line in March.
This article was originally published in The Tan Sheet
PHARMACEUTICAL RESOURCES ENTERING NUTRITIONAL SUPPLEMENTS MARKET in the beginning of March with melatonin 5 mg tablets and caplets for insomnia and jet lag. Pharmaceutical Resources currently manufactures and distributes generic Rx drugs and one OTC product -- ibuprofen -- through its Par Pharmaceutical division. The firm will form a new division called Nutraceutical Resources to market the products.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC